August 8, 2017 / 11:15 AM / 2 years ago

BRIEF-Concert Pharmaceuticals reports Q2 loss per share $0.58

1 Min Read

Aug 8 (Reuters) - Concert Pharmaceuticals Inc

* Concert Pharmaceuticals reports second quarter 2017 financial results and provides company update

* Q2 loss per share $0.58

* Q2 earnings per share view $-0.66 — Thomson Reuters I/B/E/S

* Concert Pharmaceuticals Inc - ‍company believes pro forma cash will be sufficient to fund company into 2021​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below